Cell Culture & Transfection Reagents

Biomiga GeneTranTM offers a simple and low cost tranfection reagent with low toxicity.

GeneTranTM is a Polylipid-based reagent designed and formulated with proprietary technology for transfecting DNA or siRNA into a variety of eukaryotic cell lines, including HEK293, CHO, COS, NIH3T3, MCF-7, PC12, RKO, C2C12 myoblasts, mouse embryonic stem cells (ES) and fibroblasts (MEF), mesenchymal stem cells, NCCIT, S2 (Schneider) Drosophila cells as well as primary cultures of human carcinoma, rat adrenal chromaffin cells, mouse and rat cortical neurons, hepatocytes, and etc.  GeneTranTM also offers extremely high transfection efficiencies and minimal cytotoxicity for suspension cultures including HEK 293, mouse lymphocytes, and insect cells (sf9, sf21, High-Five). The reagent works very well in cultures with serum concentration range from 0 to 20% FBS.

 

Figure 1. GFP expression in differrent cell lines:

image001_250image002_250_01image008_160image006_161_01

                    COS                                    PC12                                          HEK 293                                C2C12

Transfection of HEK293 cells with triple lentivirus vectors using GeneTran and R2000:

image007_578

GeneTran TM  III  is a proprietary formulation for the transfection of nucleic acids (DNA and RNA) into eukaryotic cells providing the...

In stock
+

GeneTran TM  III  is a proprietary formulation for the transfection of nucleic acids (DNA and RNA) into eukaryotic cells providing the...

In stock
+

Low Toxicity, High Efficiency, Low Cost Biomiga  GeneTran TM  Features Exceptional efficiency of transfection for...

In stock
+

GeneTran TM is a Polylipid-based reagent designed and formulated with proprietary technology for transfecting DNA or siRNA into a variety of...

In stock
+

Low Toxicity, High Efficiency, Low Cost Biomiga  GeneTran TM  Features Exceptional efficiency of transfection for...

In stock
+

Low Toxicity, High Efficiency, Low Cost Biomiga  GeneTran TM  Features Exceptional efficiency of transfection for...

In stock
+

Features An additional proprietary reagent was developed to boost transient expression of antibody of interest by 10-30% from the...

In stock
+

Features An additional proprietary reagent was developed to boost transient expression of antibody of interest by 10-30% from the...

In stock
+

Features An additional proprietary reagent was developed to boost transient expression of antibody of interest by 10-30% from the...

In stock
+

Features An additional proprietary reagent was developed to boost transient expression of antibody of interest by 10-30% from the...

In stock
+